Chronic myeloid leukemia (CML) is a type of stem cell-derived hematopoietic cancer marked through a t (9;22) (q34;q11) chromosome translocation that gives rise to the oncogenic fusion gene bcr-abl. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.